Bernick, Glickman Named Interim CO-CEOs at TherapeuticsMD
12 September 2022 - - US-based women's healthcare company TherapeuticsMD, Inc. (NASDAQ: TXMD) has appointed Dr. Brian Bernick and Mark Glickman as the company's Interim co-chief executive officers and co-principal executive officers, the company said.

Dr. Bernick and Glickman succeed Hugh O'Dowd as the company's chief executive officer.

Prior to this appointment, Dr. Bernick, the company's co-founder, served as chief scientific and Medical officer, and Glickman served as Chief business officer.

The company also announced that the board of directors appointed The Honorable Tommy Thompson, who served as the company's chairman of the board since 2012, as the Executive chairman of the board.

TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women.

TherapeuticsMD's products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management.

TherapeuticsMD is committed to advancing the health of women and championing awareness of their healthcare issues.